Bridgewater Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Bridgewater Advisors's ABBV Position: Q2 2026 in Review
Bridgewater Advisors reduced its AbbVie (ABBV) stake by 1% in Q2 2026, selling an estimated $21.7K and leaving 9,702 shares worth $2.38M. The position accounts for 0.13% of the portfolio, ranked #81.
Bridgewater Advisors first reported a position in ABBV in Q2 2021 and has held it in 11 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Bridgewater Advisors held 9,702 shares of AbbVie worth $2.38M as of Q2 2026.
- Bridgewater Advisors sold 101 AbbVie shares in Q2 2026, an estimated $21.7K.
- AbbVie made up 0.13% of Bridgewater Advisors's portfolio in Q2 2026, its #81 holding.
- Bridgewater Advisors first reported a position in AbbVie in Q2 2021 and has held it in 11 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Bridgewater Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.